A Clinical Trial of Cytotoxic T Cells Augmenting Autologous Hematopoietic Stem Cell (AHSC) Transplantation for Acute Myeloid Leukemia (AML)

NCT00808080 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped lack of accrual

Conditions

AML

Interventions

BIOLOGICAL: AMLCTL

Sponsor

Thomas A. Lane, MD